Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco Preferred Shares UCITS ETF Acc

PRAC · IE00BG482169 · class Acc · USD · domicile Ireland
Equity · North AmericaSFDR art. 6
Index tracked: ICE BofA Diversified Core Plus Fixed Rate Preferred Securities Net Total Return Index
TER
0.50%+ trans. 0.04%
Fund size
160 m EUR
Tracking difference
+0.78%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 7 Dec 2018 · costs from the KID as of 14 Aug 2026 · 263 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve the performance of the ICE BofA Diversified Core Plus Fixed Rate Preferred Securities Net Total Return Index (the "Index"), less fees, expenses and transaction costs. Intended Retail Investor The Fund is intended for investors aiming for medium term capital growth, who may not have specific financial expertise but are able to make an informed investment decision based on this document, the supplement, and the prospectus, have a risk appetite consistent with the risk indicator displayed below…

Performance since series start (in euro) — base 100

7 Dec 201813 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201920212023202513086113
High 130 (3 Aug 2022) · low 86 (18 Mar 2020) · last 113. Past performance is not indicative of future results.

Returns in euro

1 year−0.5%
3 years+5.8%
5 years−7.7%
10 yearsseries too young
Since series start+13.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)5.23%8.11%10.48%
Max drawdown−6.54%−11.21%−25.57%
Sharpe-1.080.07-0.41
Sortino-1.460.09-0.57
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PRAC · IE00BG4821691
RebalixPRAC · IE00BG482169 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+2.57%+1.57%+1.00%
2024+5.57%+5.01%+0.57%
2023+8.59%+7.82%+0.77%
2022−21.56%−22.13%+0.57%
2021+2.62%+1.73%+0.90%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 263 securities · top-10 weight = 13.1%
Top holdingsWeight
JPMORGAN CHASE & CO USD 25.0000 PFD1.8%
JPMORGAN CHASE & CO USD 25.0000 PFD1.5%
WELLS FARGO & COMPANY USD 25.0000 PFD1.4%
JPMORGAN CHASE & CO USD 25.0000 PFD1.3%
JPMORGAN CHASE & CO USD 25.0000 PFD1.3%
BANK OF AMERICA CORP USD 25.0000 PFD1.3%
AT&T INC USD 25.0000 PFD1.2%
BANK OF AMERICA CORP USD 25.0000 PFD1.1%
JPMORGAN CHASE & CO USD 25.0000 PFD1.1%
CAPITAL ONE FINANCIAL CO USD 25.0000 PFD1.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
XAT3 · Börse München / gettex
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BG482169
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PRAC · IE00BG4821692